Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Mucosal tolerance has been considered a potentially important pathway for the treatment of autoimmune disease, including human multiple sclerosis and experimental conditions such as experimental autoimmune encephalomyelitis (EAE). There is limited information on the capacity of commensal gut bacteria to induce and maintain peripheral immune tolerance. Inbred SJL and C57BL/6 mice were treated orally with a broad spectrum of antibiotics to reduce gut microflora. Reduction of gut commensal bacteria impaired the development of EAE. Intraperitoneal antibiotic-treated mice showed no significant decline in the gut microflora and developed EAE similar to untreated mice, suggesting that reduction in disease activity was related to alterations in the gut bacterial population. Protection was associated with a reduction of proinflammatory cytokines and increases in IL-10 and IL-13. Adoptive transfer of low numbers of IL-10-producing CD25+CD4+ T cells (>75% FoxP3+) purified from cervical lymph nodes of commensal bacteria reduced mice and in vivo neutralization of CD25+ cells suggested the role of regulatory T cells maintaining peripheral immune homeostasis. Our data demonstrate that antibiotic modification of gut commensal bacteria can modulate peripheral immune tolerance that can protect against EAE. This approach may offer a new therapeutic paradigm in the treatment of multiple sclerosis and perhaps other autoimmune conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“depletion of gut commensal bacteria by antibiotic treatment dampens the progression of experimental autoimmune encephalomyelitis in mice, which is suggested to be mediated by induction of IL-10-producing regulatory T cells.245”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [245]
In the citing paper
“Kasper L.’s group showed that oral but not systemic treatment with a classical pool of broad-spectrum antibiotics (ampicillin, vancomycin, neomycin, and metronidazole) ameliorated the development of acute EAE, in two mouse models (on C57BL/6 and SJL backgrounds) (18).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [18]
In the citing paper
“This effect suggested that the intestinal microbiota was responsible for the disease severity and the modulation of the adaptive immune response during disease development (18).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [18]
In the citing paper
“The better disease outcome upon oral antibiotic treatment was associated with a reduction of pro-inflammatory cytokines and an increase in regulatory cytokines like IL-10 (18).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 3×
“To test whether gut commensal bacteria are involved in the control of inflammatory demyelinating disease, we utilized a broad spectrum of antibiotics (ampicillin, vancomycin, neomycin sulfate, and metronidazole) to reduce the gut commensal bacteria in EAEsusceptible SJL mice (15).”
BackgroundInfluentialEcological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358
Coombes, J. L., Siddiqui, K. R. R., Arancibia-Cárcamo, C. V., Hall, J., Sun, C.-M., Belkaid, Y., & Powrie, F. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070590 · Cited by 2,710
Commensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
Sun, C.-M., Hall, J. A., Blank, R. B., Bouladoux, N., Oukka, M., Mora, J. R., & Belkaid, Y. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070602 · Cited by 1,881
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865 · cited 1×
“The role of IL-17 in the development of EAE has been of interest (34, 35).”
BackgroundIvanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Shevach, E. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.010 · Cited by 1,754
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
Artis, D. (2008) · Nature reviews. Immunology · doi:10.1038/nri2316 · Cited by 1,136 · cited 1×
“Pathogens share the same mucosa and it is the role of the immune system to control concurrently the responses to commensal and pathogenic organisms (3).”
BackgroundBenson, M. J., Pino-Lagos, K., Rosemblatt, M., & Noelle, R. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070719 · Cited by 847
Research works printed but not linked: 1
- 1999, Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response., 6249
Cited by
Items 101–200 of 635
Abdollahi‐Roodsaz, S., Abramson, S. B., & Scher, J. U. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.68 · Cited by 150
Gheorghe, C. E., Ritz, N. L., Martin, J. A., Wardill, H. R., Cryan, J. F., & Clarke, G. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1941711 · Cited by 148
Secher, T., Kassem, S., Benamar, M., Bernard, I., Boury, M., Barreau, F., Oswald, E., & Saoudi, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01096 · Cited by 148
Buscarinu, M. C., Cerasoli, B., Annibali, V., Policano, C., Lionetto, L., Capi, M., Mechelli, R., Romano, S., Fornasiero, A., Mattei, G., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516652498 · Cited by 146
The Gut Microbiome and Multiple Sclerosis
Ochoa‐Repáraz, J., Kirby, T. O., & Kasper, L. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029017 · Cited by 146
Self-citationLuchtman, D. W., Ellwardt, E., Larochelle, C., & Zipp, F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.013 · Cited by 145
Microbiota and neurologic diseases: potential effects of probiotics
Umbrello, G., & Esposito, S. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1058-7 · Cited by 143
Ochoa-Repáraz, J., Mielcarz, D. W., Haque-Begum, S., & Kasper, L. H. (2010) · Gut Microbes · doi:10.4161/gmic.1.2.11515 · Cited by 143
Self-citationCarrillo-Salinas, F. J., Anastasiou, M., Ngwenyama, N., Kaur, K., Tai, A., Smolgovsky, S. A., Jetton, D., Aronovitz, M., & Alcaide, P. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1823801 · Cited by 143
The Role of Microbiome in Brain Development and Neurodegenerative Diseases
Nandwana, V., Nandwana, N. K., Das, Y., Saito, M., Panda, T., Das, S., Almaguel, F. A., Hosmane, N. S., & Das, B. C. (2022) · Molecules · doi:10.3390/molecules27113402 · Cited by 140
Masetti, G., Moshkelgosha, S., Köhling, H.-L., Covelli, D., Banga, J. P., Berchner‐Pfannschmidt, U., Horstmann, M., Díaz‐Cano, S. J., Goertz, G.-E., Plummer, S. F., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0478-4 · Cited by 137
Takata, K., Kinoshita, M., Okuno, T., Moriya, M., Kohda, T., Honorat, J. A., Sugimoto, T., Kumanogoh, A., Kayama, H., Takeda, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027644 · Cited by 135
Regulation of common neurological disorders by gut microbial metabolites
Park, J., & Kim, C. H. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00703-x · Cited by 136
The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders?
Ochoa-Repáraz, J., & Kasper, L. H. (2016) · Current Obesity Reports · doi:10.1007/s13679-016-0191-1 · Cited by 132
Self-citationGut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases
Belvončíková, P., Marônek, M., & Gardlík, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810729 · Cited by 132
Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases
Grigg, J. B., & Sonnenberg, G. F. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601621 · Cited by 130
“For instance, mice treated with antibiotics (60) or reared in germ-free conditions (61) show reduced induction of experimental autoimmune”
BackgroundRogier, R., Evans-Marin, H., Manasson, J., van der Kraan, P. M., Walgreen, B., Helsen, M. M., van den Bersselaar, L. A., van de Loo, F. A., van Lent, P. L., Abramson, S. B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15802-x · Cited by 130
Gut Microbiome and Multiple Sclerosis
Bhargava, P., & Mowry, E. M. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0492-2 · Cited by 129
Tirelle, P., Breton, J., Riou, G., Déchelotte, P., Coëffier, M., & Ribet, D. (2020) · BMC Microbiology · doi:10.1186/s12866-020-02018-9 · Cited by 129
Arthritis susceptibility and the gut microbiome
Taneja, V. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.05.034 · Cited by 128
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
Kirby, T. O., & Ochoa‐Repáraz, J. (2018) · Medical Sciences · doi:10.3390/medsci6030069 · Cited by 130
Self-citationCellular and Molecular Mechanisms of Autoimmune Disease
Bolon, B. N. (2011) · Toxicologic Pathology · doi:10.1177/0192623311428481 · Cited by 127
The Gut-Microglia Connection: Implications for Central Nervous System Diseases
Wang, Y., Wang, Z., Wang, Y., Li, F., Jia, J., Song, X., Qin, S., Wang, R., Jin, F., Kitazato, K., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02325 · Cited by 125
Parodi, B., & de Rosbo, N. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718220 · Cited by 125
Functional immune cell–astrocyte interactions
Sanmarco, L. M., Polonio, C. M., Wheeler, M. A., & Quintana, F. J. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202715 · Cited by 123
Wang, Y., Begum-Haque, S., Telesford, K. M., Ochoa-Repáraz, J., Christy, M., Kasper, E. J., Kasper, D. L., Robson, S. C., & Kasper, L. H. (2014) · Gut Microbes · doi:10.4161/gmic.29797 · Cited by 122
Self-citationDisease-modifying therapies alter gut microbial composition in MS
Sand, I. K., Zhu, Y., Ntranos, A., Clemente, J. C., Cekanaviciute, E., Brandstadter, R., Crabtree‐Hartman, E., Singh, S., Bencosme, Y., Debelius, J. W., et al. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000517 · Cited by 122
Targeting the gut to treat multiple sclerosis
Ghezzi, L., Cantoni, C., Pinget, G. V., Zhou, Y., & Piccio, L. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143774 · Cited by 122
Abarbanel, D. N., Seki, S. M., Davies, Y., Marlen, N., Benavides, J. A., Cox, K., Nadeau, K. C., & Cox, K. L. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9801-1 · Cited by 121
Autoimmune host–microbiota interactions at barrier sites and beyond
Ruff, W. E., & Kriegel, M. A. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.006 · Cited by 121
Shih, V. F.-S., Cox, J. H., Kljavin, N. M., Dengler, H. S., Reichelt, M., Kumar, P., Rangell, L. K., Kolls, J. K., Diehl, L. J., Ouyang, W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323852111 · Cited by 121
Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation
Zundler, S., Günther, C., Kremer, A. E., Zaiss, M. M., Rothhammer, V., & Neurath, M. F. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00663-1 · Cited by 118
Relationship between gut microbiota and development of T cell associated disease
Kosiewicz, M. M., Dryden, G. W., Chhabra, A., & Alard, P. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.019 · Cited by 117
Role of Metabolism in the Immunobiology of Regulatory T Cells
Galgani, M., De Rosa, V., La Cava, A., & Matarese, G. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600242 · Cited by 116
The Gut Microbiome in Multiple Sclerosis
Mielcarz, D. W., & Kasper, L. H. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0344-7 · Cited by 115
Self-citationDing, W., You, Z., Chen, Q., Yang, L., Doheny, J. T., Zhou, X. P., Li, N., Wang, S., Hu, K., Chen, L. L., et al. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005155 · Cited by 115
Duc, D., Vigne, S., Bernier‐Latmani, J., Yersin, Y., Ruiz, F., Gaïa, N., Léo, S., Lazarević, V., Schrenzel, J., Petrova, T. V., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.002 · Cited by 113
Epithelial‐microbial crosstalk in polymeric Ig receptor deficient mice
Reikvam, D. H., Derrien, M., Islam, R., Erofeev, A., Grcic, V., Sandvik, A., Gaustad, P., Meza‐Zepeda, L. A., Jahnsen, F. L., Smidt, H., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201242543 · Cited by 111
An unexplored brain-gut microbiota axis in stroke
Wen, S., & Wong, C. H. Y. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1344809 · Cited by 111
Levi, I., Gurevich, M., Perlman, G., Magalashvili, D., Menascu, S., Bar, N., Godneva, A., Zahavi, L., Chermon, D., Kosower, N., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100246 · Cited by 111
Infectome: A platform to trace infectious triggers of autoimmunity
Bogdanos, D. P., Smyk, D. S., Invernizzi, P., Rigopoulou, E. I., Blank, M., Pouria, S., & Shoenfeld, Y. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.12.005 · Cited by 109
Brain Autoimmunity and Intestinal Microbiota: 100 Trillion Game Changers
Wekerle, H. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.03.008 · Cited by 109
Type 1 diabetes: role of intestinal microbiome in humans and mice
Boerner, B. P., & Sarvetnick, N. E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06340.x · Cited by 107
Gut microbiota and immunity relevance in eubiosis and dysbiosis
Al-Rashidi, H. E. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.10.068 · Cited by 105
Chen, L.-W., Chen, P.-H., & Hsu, C.-M. (2011) · Shock · doi:10.1097/shk.0b013e3182184ee7 · Cited by 104
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis
Calvo‐Barreiro, L., Eixarch, H., Montalbán, X., & Espejo, C. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.11.019 · Cited by 105
Gut Microbiota Interaction with the Central Nervous System throughout Life
Ojeda, J., Ávila, A., & Vidal, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061299 · Cited by 103
Vitamin D, multiple sclerosis and inflammatory bowel disease
Cantorna, M. T. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.11.001 · Cited by 99
Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases
Bernstein, C. N., & Forbes, J. D. (2017) · Inflammatory Intestinal Diseases · doi:10.1159/000481401 · Cited by 99
Rogier, R., Ederveen, T. H. A., Boekhorst, J., Wopereis, H., Scher, J. U., Manasson, J., Frambach, S. J. C. M., Knol, J., Garssen, J., van der Kraan, P. M., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0278-2 · Cited by 98
The microbiota–microglia axis in central nervous system disorders
Mossad, O., & Erny, D. (2020) · Brain Pathology · doi:10.1111/bpa.12908 · Cited by 98
Gut microbiome interventions in human health and diseases
Nie, P., Li, Z., Wang, Y., Zhang, Y., Zhao, M., Luo, J., Du, S., Deng, Z., Chen, J., Wang, Y., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21584 · Cited by 99
Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance
Chistiakov, D. A., Bobryshev, Y. V., Kozarov, E., Sobenin, I. A., & Orekhov, A. N. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00781 · Cited by 97
The gut microbiome and microbial translocation in multiple sclerosis
Mirza, A., & Mao‐Draayer, Y. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.03.001 · Cited by 97
Chen, H., Ma, X., Liu, Y., Ma, L., Chen, Z., Lin, X., Si, L., Ma, X., & Chen, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01662 · Cited by 96
“Antibiotics can easily affect the components of the gut microbiota and alleviate EAE (10, 11).”
BackgroundMicrobiota–immune system interaction: an uneasy alliance
Salzman, N. H. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.018 · Cited by 96
“SFB has been shown to drive both autoimmune arthritis [62 ] and EAE [61 ] through Th17 mechanisms, while both disease processes are attenuated in germ-free animals.”
BackgroundInfluentialGandy, K. A. O., Zhang, J., Nagarkatti, P., & Nagarkatti, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-43356-7 · Cited by 95
Colpitts, S. L., Kasper, E. J., Keever, A., Liljenberg, C., Kirby, T., Magori, K., Kasper, L. H., & Ochoa-Repáraz, J. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1353843 · Cited by 93
Self-citationProtection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis
Li, K., Wei, S., Hu, L., Yin, X., Mai, Y., Jiang, C., Peng, X., Cao, X., Huang, Z., Zhou, H., et al. (2020) · Mediators of Inflammation · doi:10.1155/2020/2058272 · Cited by 92
The Gut–CNS Axis in Multiple Sclerosis
Kadowaki, A., & Quintana, F. J. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.06.002 · Cited by 92
Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease
Rossi, B., Santos-Lima, B., Terrabuio, E., Zenaro, E., & Constantin, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639369 · Cited by 92
Brain modulation by the gut microbiota: From disease to therapy
Mitra, S., Dash, R., Nishan, A. A., Habiba, S. U., & Moon, I. S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2022.12.001 · Cited by 91
Stroke affects intestinal immune cell trafficking to the central nervous system
Brea, D., Poon, C., Benakis, C., Lubitz, G. S., Murphy, M., Iadecola, C., & Anrather, J. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.05.008 · Cited by 91
Almeida, L., Dhillon-LaBrooy, A., Castro, C. N., Adossa, N., Carriche, G. M., Guderian, M., Lippens, S., Dennerlein, S., Hesse, C., Lambrecht, B. N., et al. (2021) · Immunity · doi:10.1016/j.immuni.2020.11.001 · Cited by 90
The role of the intestinal microbiome in ocular inflammatory disease
Lin, P. (2018) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000465 · Cited by 90
Johanson, D. M., Goertz, J. E., Marin, I. A., Costello, J., Overall, C. C., & Gaultier, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-72197-y · Cited by 87
Bianchimano, P., Britton, G. J., Wallach, D. S., Smith, E. M., Cox, L. M., Liu, S., Iwanowski, K., Weiner, H. L., Faith, J. J., Clemente, J. C., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01364-2 · Cited by 87
Tissue-specific immunity in helminth infections
Vacca, F., & Le Gros, G. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00531-w · Cited by 86
Cui, Y., Yu, H., Bu, Z., Wen, L., Yan, L.-L., & Feng, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.894298 · Cited by 86
Ericsson, A. C., Personett, A. R., Turner, G., Dorfmeyer, R. A., & Franklin, C. L. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00196 · Cited by 86
Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
Buscarinu, M. C., Romano, S., Mechelli, R., Umeton, R. P., Ferraldeschi, M., Fornasiero, A., Reniè, R., Cerasoli, B., Morena, E., Romano, C., et al. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0582-3 · Cited by 84
Gut Microbiota in Neurological Disorders
Grochowska, M., Laskus, T., & Radkowski, M. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00561-6 · Cited by 84
Commensal gut flora and brain autoimmunity: a love or hate affair?
Berer, K., & Krishnamoorthy, G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0949-9 · Cited by 82
Time to include the gut microbiota in the hygienic standardisation of laboratory rodents
Bleich, A., & Hansen, A. K. (2012) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2011.12.006 · Cited by 82
Wu, H., Wang, J., Teng, T., Yin, B., He, Y., Jiang, Y., Liu, X., Yu, Y., Li, X., & Zhou, X. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.11.058 · Cited by 81
Mechanisms of microbial–neuronal interactions in pain and nociception
Lagomarsino, V. N., Kostic, A. D., & Chiu, I. M. (2020) · Neurobiology of Pain · doi:10.1016/j.ynpai.2020.100056 · Cited by 80
Dorożyńska, I., Majewska‐Szczepanik, M., Marcińska, K., & Szczepanik, M. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.09.007 · Cited by 79
Toll-like receptor signaling and regulation of intestinal immunity
Kamdar, K., Nguyen, V., & DePaolo, R. W. (2013) · Virulence · doi:10.4161/viru.23354 · Cited by 78
Human Microbiome: When a Friend Becomes an Enemy
Muszer, M., Noszczyńska, M., Kasperkiewicz, K., & Skurnik, M. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0332-3 · Cited by 77
Novel perspectives on therapeutic modulation of the gut microbiota
McCarville, J. L., Caminero, A., & Verdu, E. F. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16637819 · Cited by 76
Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity
Okamura, T., Hamaguchi, M., Bamba, R., Nakajima, H., Yoshimura, Y., Kimura, T., Hashimoto, Y., Majima, S., Senmaru, T., Ushigome, E., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13076 · Cited by 76
Western lifestyle and immunopathology of multiple sclerosis
Matveeva, O., Bogie, J. F. J., Hendriks, J. J. A., Linker, R. A., Haghikia, A., & Kleinewietfeld, M. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13583 · Cited by 76
The Gut Microbiome as a Regulator of the Neuroimmune Landscape
Yu, L. W., Agirman, G., & Hsiao, E. Y. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-014237 · Cited by 75
Th17 cell pathogenicity in autoimmune disease
Park, E., & Ciofani, M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01535-9 · Cited by 75
“In germ-free mice or mice with altered gut microbiota, EAE development is delayed or attenuated, demonstrating the essential role of commensal bacteria in pathogenic Th17 cell development 208 – 210 .”
The new link between gut–brain axis and neuropsychiatric disorders
Fetissov, S. O., & Déchelotte, P. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834936e7 · Cited by 74
van den Hoogen, W. J., Laman, J. D., & ’t Hart, B. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01081 · Cited by 74
Immune mechanisms and shared immune targets in neurodegenerative diseases
Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 74
Autophagy and Autoimmunity Crosstalks
Bhattacharya, A., & Eissa, N. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00088 · Cited by 73
Interrelation of Diet, Gut Microbiome, and Autoantibody Production
Petta, I., Fraussen, J., Somers, V., & Kleinewietfeld, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00439 · Cited by 72
The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
Buscarinu, M. C., Fornasiero, A., Romano, S., Ferraldeschi, M., Mechelli, R., Reniè, R., Morena, E., Romano, C., Pellicciari, G., Landi, A. C., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01916 · Cited by 72
Kapur, R., Kim, M. H., Rebetz, J., Hallström, B. M., Björkman, J., Takabe-French, A., Kim, N., Liu, J., Shanmugabhavananthan, S., Milosevic, S., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018018903 · Cited by 71
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature
Cohen, N. A., & Maharshak, N. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4535-9 · Cited by 71
Zárate-Bladés, C. R., Horai, R., Mattapallil, M. J., Ajami, N. J., Wong, M. C., Petrosino, J. F., Itoh, K., Chan, C., & Caspi, R. R. (2017) · Gut Microbes · doi:10.1080/19490976.2016.1273996 · Cited by 69
Impact of intestinal disorders on central and peripheral nervous system diseases
El-Hakim, Y., Bake, S., Mani, K. K., & Sohrabji, F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105627 · Cited by 69
Exploring the Gut Microbiome in Myasthenia Gravis
Thye, A. Y.-K., Law, J. W., Tan, L. T., Thurairajasingam, S., Chan, K., Letchumanan, V., & Lee, L. (2022) · Nutrients · doi:10.3390/nu14081647 · Cited by 69
The human gut microbiota is neither an organ nor a commensal
Riccio, P., & Rossano, R. (2020) · FEBS Letters · doi:10.1002/1873-3468.13946 · Cited by 69
The role of the gut microbiota and microbial metabolites in neuroinflammation
Haase, S., Wilck, N., Haghikia, A., Gold, R., Mueller, D. N., & Linker, R. A. (2020) · European Journal of Immunology · doi:10.1002/eji.201847807 · Cited by 68
Kell, D. B., Potgieter, M., & Pretorius, E. (2015) · F1000Research · doi:10.12688/f1000research.6709.2 · Cited by 67
Zeraati, M., Enayati, M., Kafami, L., Shahidi, S. H., & Salari, A.-A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107685 · Cited by 66
Influence of the Gut Microbiome on Autoimmunity in the Central Nervous System
Colpitts, S. L., & Kasper, L. H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601438 · Cited by 66
Self-citation
Metadata
- Authors
- Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., & Kasper, L. H.
- Affiliations
- Department of Medicine
- Dartmouth College (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 183
- Issue
- 10
- Pages
- 6041-6050
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2112999168
- Cited by
- 590
- References
- 35
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 31 · 2023: 39 · 2022: 46 · 2021: 63 · 2020: 55 · 2019: 37 · 2018: 60 · 2017: 49 · 2016: 35 · 2015: 30 · 2014: 35 · 2013: 20 · 2012: 17
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Multiple Sclerosis Society (CA1027A1/3)
- Teva Pharmaceutical Industries
- Dartmouth College
- Multiple Sclerosis Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- gut commensal bacteria, experimental autoimmune encephalomyelitis, mucosal tolerance, peripheral tolerance, antibiotic-induced dysbiosis, multiple sclerosis, regulatory T cells, Foxp3, IL-10, IL-13, inflammatory cytokines, CD4+CD25+ T cells, adoptive transfer, autoimmune disease therapy
- MeSH terms
- Administration, Oral, Animals, Anti-Bacterial Agents, Bacteria, Encephalomyelitis, Autoimmune, Experimental, Female, Glycoproteins, Intestines, Mice, Inbred C57BL, Peptide Fragments, Cytokines, Interleukin-10, Interleukin-13, Immunity, Mucosal, Myelin Proteolipid Protein, Adoptive Transfer, T-Lymphocytes, Regulatory, Mice, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.